Authors:
ALYEA EP
SOIFFER RJ
CANNING C
NEUBERG D
SCHLOSSMAN R
PICKETT C
COLLINS H
WANG YL
ANDERSON KC
RITZ J
Citation: Ep. Alyea et al., TOXICITY AND EFFICACY OF DEFINED DOSES OF CD4(-MARROW TRANSPLANT() DONOR LYMPHOCYTES FOR TREATMENT OF RELAPSE AFTER ALLOGENEIC BONE), Blood, 91(10), 1998, pp. 3671-3680
Citation: C. Canning, THE PLATFORM VERSUS THE STAGE - THE CIRCUIT CHAUTAUQUAS ANTITHEATRICAL THEATER, Theatre journal (Washington, D.C.), 50(3), 1998, pp. 303-318
Citation: Ep. Alyea et al., PROLONGED TIME TO CYTOGENETIC AND MOLECULAR RESPONSE IN PATIENTS WITHRELAPSED CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER DONOR LYMPHOCYTE INFUSION (DLI), Blood, 90(10), 1997, pp. 2442-2442
Authors:
ALYEA EP
CHILLEMI A
CANNING C
SOIFFER RJ
RITZ J
Citation: Ep. Alyea et al., ALLOGENEIC GRAFT-VERSUS-LEUKEMIA IS DIRECTED AGAINST HOST HEMATOPOIETIC ANTIGENS AND IS NOT LEUKEMIA SPECIFIC AS DETERMINED BY CYTOGENETIC AND MOLECULAR ANALYSIS IN PATIENTS WITH CML FOLLOWING DONOR LYMPHOCYTEINFUSION, Blood, 90(10), 1997, pp. 2620-2620
Authors:
TAPLIN ME
FRANTZ ME
CANNING C
RITZ J
BLUMBERG RS
BALK SP
Citation: Me. Taplin et al., EVIDENCE AGAINST T-CELL DEVELOPMENT IN THE ADULT HUMAN INTESTINAL-MUCOSA BASED UPON LACK OF TERMINAL DEOXYNUCLEOTIDYLTRANSFERASE EXPRESSION, Immunology, 87(3), 1996, pp. 402-407
Citation: R. Davies et al., SIMULATION OF DIABETIC EYE DISEASE TO COMPARE SCREENING POLICIES, British journal of ophthalmology, 80(11), 1996, pp. 945-950
Authors:
ORSINI E
CLARET EJ
ALYEA EP
SCHLOSSMAN R
CANNING C
SOIFFER RJ
ANDERSON KC
RITZ J
Citation: E. Orsini et al., DISTINCT CHANGES IN T-CELL REPERTOIRE ASSOCIATED WITH GVL AND GVHD INPATIENTS RECEIVING DONOR LYMPHOCYTE INFUSION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 1020-1020
Authors:
ALYEA EP
CANNING C
COLLINS H
PICKETT C
WANG Y
SOIFFER RJ
RITZ J
Citation: Ep. Alyea et al., EFFICACY AND TOXICITY OF CD4-LYMPHOCYTE INFUSION FOR TREATMENT OF RELAPSED CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER ALLOGENEIC BMT( DONOR T), Blood, 88(10), 1996, pp. 2715-2715
Citation: Rj. Soiffer et al., INFLUENCE OF LOW-DOSE INTERLEUKIN-2 ON RELAPSE RATE AFTER T-CELL DEPLETED ALLOGENEIC BMT, Blood, 82(10), 1993, pp. 10000215-10000215